BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-146@pharmaconomics
DTSTAMP:20260707T033828Z
DTSTART;VALUE=DATE:20250903
DTEND;VALUE=DATE:20250904
SUMMARY:ABBV Approval — Skyrizi
DESCRIPTION:A final FDA approval decision on Skyrizi for its lead indication is expected Sep 3\, 2025.\n\nPrimary source: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761262\n\nTrack it: https://pharmaconomics.com/e/146
URL:https://pharmaconomics.com/e/146
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:ABBV catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR